Global Solid-phase Oligonucleotide Synthesis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 102

Published Date: 01 Sep 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Solid-phase Oligonucleotide Synthesis market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD 1230 million by 2029 with a CAGR of 16.1% during review period.

The Global Info Research report includes an overview of the development of the Solid-phase Oligonucleotide Synthesis industry chain, the market status of Commercial (Primers, Probes), Academic Research (Primers, Probes), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Solid-phase Oligonucleotide Synthesis.

Regionally, the report analyzes the Solid-phase Oligonucleotide Synthesis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Solid-phase Oligonucleotide Synthesis market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Solid-phase Oligonucleotide Synthesis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Solid-phase Oligonucleotide Synthesis industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Primers, Probes).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Solid-phase Oligonucleotide Synthesis market.

Regional Analysis: The report involves examining the Solid-phase Oligonucleotide Synthesis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Solid-phase Oligonucleotide Synthesis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Solid-phase Oligonucleotide Synthesis:
Company Analysis: Report covers individual Solid-phase Oligonucleotide Synthesis players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Solid-phase Oligonucleotide Synthesis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Commercial, Academic Research).

Technology Analysis: Report covers specific technologies relevant to Solid-phase Oligonucleotide Synthesis. It assesses the current state, advancements, and potential future developments in Solid-phase Oligonucleotide Synthesis areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Solid-phase Oligonucleotide Synthesis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Solid-phase Oligonucleotide Synthesis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Primers
    Probes
    Intermediate-scale Synthesis Oligos
    Large-scale Synthesis Oligos
    Linkers and Adaptors

Market segment by Application
    Commercial
    Academic Research

Market segment by players, this report covers
    Genescript
    GeneArt (Thermofischer)
    Renesas Electronics Corporation
    DNA 2.0 (ATUM)
    OriGene
    BBI
    Genewiz
    Eurofins Genomics
    Gene Oracle
    SBS Genetech
    Bio Basic

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Solid-phase Oligonucleotide Synthesis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Solid-phase Oligonucleotide Synthesis, with revenue, gross margin and global market share of Solid-phase Oligonucleotide Synthesis from 2018 to 2023.
Chapter 3, the Solid-phase Oligonucleotide Synthesis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Solid-phase Oligonucleotide Synthesis market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Solid-phase Oligonucleotide Synthesis.
Chapter 13, to describe Solid-phase Oligonucleotide Synthesis research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Solid-phase Oligonucleotide Synthesis
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Solid-phase Oligonucleotide Synthesis by Type
        1.3.1 Overview: Global Solid-phase Oligonucleotide Synthesis Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Type in 2022
        1.3.3 Primers
        1.3.4 Probes
        1.3.5 Intermediate-scale Synthesis Oligos
        1.3.6 Large-scale Synthesis Oligos
        1.3.7 Linkers and Adaptors
    1.4 Global Solid-phase Oligonucleotide Synthesis Market by Application
        1.4.1 Overview: Global Solid-phase Oligonucleotide Synthesis Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Commercial
        1.4.3 Academic Research
    1.5 Global Solid-phase Oligonucleotide Synthesis Market Size & Forecast
    1.6 Global Solid-phase Oligonucleotide Synthesis Market Size and Forecast by Region
        1.6.1 Global Solid-phase Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Solid-phase Oligonucleotide Synthesis Market Size by Region, (2018-2029)
        1.6.3 North America Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
        1.6.4 Europe Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
        1.6.6 South America Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Genescript
        2.1.1 Genescript Details
        2.1.2 Genescript Major Business
        2.1.3 Genescript Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.1.4 Genescript Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Genescript Recent Developments and Future Plans
    2.2 GeneArt (Thermofischer)
        2.2.1 GeneArt (Thermofischer) Details
        2.2.2 GeneArt (Thermofischer) Major Business
        2.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.2.4 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GeneArt (Thermofischer) Recent Developments and Future Plans
    2.3 Renesas Electronics Corporation
        2.3.1 Renesas Electronics Corporation Details
        2.3.2 Renesas Electronics Corporation Major Business
        2.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.3.4 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Renesas Electronics Corporation Recent Developments and Future Plans
    2.4 DNA 2.0 (ATUM)
        2.4.1 DNA 2.0 (ATUM) Details
        2.4.2 DNA 2.0 (ATUM) Major Business
        2.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.4.4 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 DNA 2.0 (ATUM) Recent Developments and Future Plans
    2.5 OriGene
        2.5.1 OriGene Details
        2.5.2 OriGene Major Business
        2.5.3 OriGene Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.5.4 OriGene Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 OriGene Recent Developments and Future Plans
    2.6 BBI
        2.6.1 BBI Details
        2.6.2 BBI Major Business
        2.6.3 BBI Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.6.4 BBI Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 BBI Recent Developments and Future Plans
    2.7 Genewiz
        2.7.1 Genewiz Details
        2.7.2 Genewiz Major Business
        2.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.7.4 Genewiz Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Genewiz Recent Developments and Future Plans
    2.8 Eurofins Genomics
        2.8.1 Eurofins Genomics Details
        2.8.2 Eurofins Genomics Major Business
        2.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.8.4 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Eurofins Genomics Recent Developments and Future Plans
    2.9 Gene Oracle
        2.9.1 Gene Oracle Details
        2.9.2 Gene Oracle Major Business
        2.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.9.4 Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Gene Oracle Recent Developments and Future Plans
    2.10 SBS Genetech
        2.10.1 SBS Genetech Details
        2.10.2 SBS Genetech Major Business
        2.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.10.4 SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 SBS Genetech Recent Developments and Future Plans
    2.11 Bio Basic
        2.11.1 Bio Basic Details
        2.11.2 Bio Basic Major Business
        2.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.11.4 Bio Basic Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Bio Basic Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Solid-phase Oligonucleotide Synthesis Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Solid-phase Oligonucleotide Synthesis by Company Revenue
        3.2.2 Top 3 Solid-phase Oligonucleotide Synthesis Players Market Share in 2022
        3.2.3 Top 6 Solid-phase Oligonucleotide Synthesis Players Market Share in 2022
    3.3 Solid-phase Oligonucleotide Synthesis Market: Overall Company Footprint Analysis
        3.3.1 Solid-phase Oligonucleotide Synthesis Market: Region Footprint
        3.3.2 Solid-phase Oligonucleotide Synthesis Market: Company Product Type Footprint
        3.3.3 Solid-phase Oligonucleotide Synthesis Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Solid-phase Oligonucleotide Synthesis Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Application (2018-2023)
    5.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
    6.2 North America Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2029)
    6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country
        6.3.1 North America Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
        6.3.2 United States Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        6.3.3 Canada Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        6.3.4 Mexico Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
    7.2 Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2029)
    7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country
        7.3.1 Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
        7.3.2 Germany Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        7.3.3 France Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        7.3.5 Russia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        7.3.6 Italy Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region
        8.3.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Region (2018-2029)
        8.3.2 China Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        8.3.3 Japan Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        8.3.4 South Korea Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        8.3.5 India Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        8.3.7 Australia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
    9.2 South America Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2029)
    9.3 South America Solid-phase Oligonucleotide Synthesis Market Size by Country
        9.3.1 South America Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
        9.3.2 Brazil Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        9.3.3 Argentina Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country
        10.3.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
        10.3.2 Turkey Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
        10.3.4 UAE Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Solid-phase Oligonucleotide Synthesis Market Drivers
    11.2 Solid-phase Oligonucleotide Synthesis Market Restraints
    11.3 Solid-phase Oligonucleotide Synthesis Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Solid-phase Oligonucleotide Synthesis Industry Chain
    12.2 Solid-phase Oligonucleotide Synthesis Upstream Analysis
    12.3 Solid-phase Oligonucleotide Synthesis Midstream Analysis
    12.4 Solid-phase Oligonucleotide Synthesis Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Solid-phase Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Solid-phase Oligonucleotide Synthesis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Solid-phase Oligonucleotide Synthesis Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Solid-phase Oligonucleotide Synthesis Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Genescript Company Information, Head Office, and Major Competitors
    Table 6. Genescript Major Business
    Table 7. Genescript Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 8. Genescript Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Genescript Recent Developments and Future Plans
    Table 10. GeneArt (Thermofischer) Company Information, Head Office, and Major Competitors
    Table 11. GeneArt (Thermofischer) Major Business
    Table 12. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 13. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. GeneArt (Thermofischer) Recent Developments and Future Plans
    Table 15. Renesas Electronics Corporation Company Information, Head Office, and Major Competitors
    Table 16. Renesas Electronics Corporation Major Business
    Table 17. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 18. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Renesas Electronics Corporation Recent Developments and Future Plans
    Table 20. DNA 2.0 (ATUM) Company Information, Head Office, and Major Competitors
    Table 21. DNA 2.0 (ATUM) Major Business
    Table 22. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 23. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. DNA 2.0 (ATUM) Recent Developments and Future Plans
    Table 25. OriGene Company Information, Head Office, and Major Competitors
    Table 26. OriGene Major Business
    Table 27. OriGene Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 28. OriGene Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. OriGene Recent Developments and Future Plans
    Table 30. BBI Company Information, Head Office, and Major Competitors
    Table 31. BBI Major Business
    Table 32. BBI Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 33. BBI Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. BBI Recent Developments and Future Plans
    Table 35. Genewiz Company Information, Head Office, and Major Competitors
    Table 36. Genewiz Major Business
    Table 37. Genewiz Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 38. Genewiz Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Genewiz Recent Developments and Future Plans
    Table 40. Eurofins Genomics Company Information, Head Office, and Major Competitors
    Table 41. Eurofins Genomics Major Business
    Table 42. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 43. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Eurofins Genomics Recent Developments and Future Plans
    Table 45. Gene Oracle Company Information, Head Office, and Major Competitors
    Table 46. Gene Oracle Major Business
    Table 47. Gene Oracle Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 48. Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Gene Oracle Recent Developments and Future Plans
    Table 50. SBS Genetech Company Information, Head Office, and Major Competitors
    Table 51. SBS Genetech Major Business
    Table 52. SBS Genetech Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 53. SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. SBS Genetech Recent Developments and Future Plans
    Table 55. Bio Basic Company Information, Head Office, and Major Competitors
    Table 56. Bio Basic Major Business
    Table 57. Bio Basic Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 58. Bio Basic Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Bio Basic Recent Developments and Future Plans
    Table 60. Global Solid-phase Oligonucleotide Synthesis Revenue (USD Million) by Players (2018-2023)
    Table 61. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Players (2018-2023)
    Table 62. Breakdown of Solid-phase Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Solid-phase Oligonucleotide Synthesis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 64. Head Office of Key Solid-phase Oligonucleotide Synthesis Players
    Table 65. Solid-phase Oligonucleotide Synthesis Market: Company Product Type Footprint
    Table 66. Solid-phase Oligonucleotide Synthesis Market: Company Product Application Footprint
    Table 67. Solid-phase Oligonucleotide Synthesis New Market Entrants and Barriers to Market Entry
    Table 68. Solid-phase Oligonucleotide Synthesis Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Solid-phase Oligonucleotide Synthesis Consumption Value (USD Million) by Type (2018-2023)
    Table 70. Global Solid-phase Oligonucleotide Synthesis Consumption Value Share by Type (2018-2023)
    Table 71. Global Solid-phase Oligonucleotide Synthesis Consumption Value Forecast by Type (2024-2029)
    Table 72. Global Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2023)
    Table 73. Global Solid-phase Oligonucleotide Synthesis Consumption Value Forecast by Application (2024-2029)
    Table 74. North America Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
    Table 75. North America Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
    Table 76. North America Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. North America Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. North America Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
    Table 79. North America Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
    Table 80. Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2023) & (USD Million)
    Table 83. Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2024-2029) & (USD Million)
    Table 84. Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
    Table 87. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
    Table 88. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2023) & (USD Million)
    Table 89. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2024-2029) & (USD Million)
    Table 90. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Region (2018-2023) & (USD Million)
    Table 91. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value by Region (2024-2029) & (USD Million)
    Table 92. South America Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
    Table 93. South America Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
    Table 94. South America Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2023) & (USD Million)
    Table 95. South America Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2024-2029) & (USD Million)
    Table 96. South America Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. South America Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
    Table 100. Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2018-2023) & (USD Million)
    Table 101. Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Application (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
    Table 103. Middle East & Africa Solid-phase Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
    Table 104. Solid-phase Oligonucleotide Synthesis Raw Material
    Table 105. Key Suppliers of Solid-phase Oligonucleotide Synthesis Raw Materials
List of Figures
    Figure 1. Solid-phase Oligonucleotide Synthesis Picture
    Figure 2. Global Solid-phase Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Type in 2022
    Figure 4. Primers
    Figure 5. Probes
    Figure 6. Intermediate-scale Synthesis Oligos
    Figure 7. Large-scale Synthesis Oligos
    Figure 8. Linkers and Adaptors
    Figure 9. Global Solid-phase Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Application in 2022
    Figure 11. Commercial Picture
    Figure 12. Academic Research Picture
    Figure 13. Global Solid-phase Oligonucleotide Synthesis Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Solid-phase Oligonucleotide Synthesis Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Solid-phase Oligonucleotide Synthesis Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Region in 2022
    Figure 18. North America Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Players in 2022
    Figure 24. Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Solid-phase Oligonucleotide Synthesis Market Share in 2022
    Figure 26. Global Top 6 Players Solid-phase Oligonucleotide Synthesis Market Share in 2022
    Figure 27. Global Solid-phase Oligonucleotide Synthesis Consumption Value Share by Type (2018-2023)
    Figure 28. Global Solid-phase Oligonucleotide Synthesis Market Share Forecast by Type (2024-2029)
    Figure 29. Global Solid-phase Oligonucleotide Synthesis Consumption Value Share by Application (2018-2023)
    Figure 30. Global Solid-phase Oligonucleotide Synthesis Market Share Forecast by Application (2024-2029)
    Figure 31. North America Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Solid-phase Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
    Figure 65. Solid-phase Oligonucleotide Synthesis Market Drivers
    Figure 66. Solid-phase Oligonucleotide Synthesis Market Restraints
    Figure 67. Solid-phase Oligonucleotide Synthesis Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Solid-phase Oligonucleotide Synthesis in 2022
    Figure 70. Manufacturing Process Analysis of Solid-phase Oligonucleotide Synthesis
    Figure 71. Solid-phase Oligonucleotide Synthesis Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic

Related Reports

Global Solid-phase Oligonucleotide Synthesis Supply, Demand and Key Producers, 2023-2029

Global Solid-phase Oligonucleotide Synthesis Supply, Demand and Key Producers, 2023-2029

date 01 Sep 2023

date Medical Care

The global Solid-phase Oligonucleotide Synthesis market size is expected to reach $ 1230 million by 2029, rising at a market growth of 16.1% CAGR during the forecast period (2023-2029).

Global Solid-phase Oligonucleotide Synthesis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Solid-phase Oligonucleotide Synthesis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Solid-phase Oligonucleotide Synthesis market size was valued at USD 433.2 million in 2023 and is forecast to a readjusted size of USD 1230 million by 2030 with a CAGR of 16.1% during review period.

Global Solid-phase Oligonucleotide Synthesis Supply, Demand and Key Producers, 2024-2030

Global Solid-phase Oligonucleotide Synthesis Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Medical Care

The global Solid-phase Oligonucleotide Synthesis market size is expected to reach $ 1230 million by 2030, rising at a market growth of 16.1% CAGR during the forecast period (2024-2030).

Product Tags

Solid-phase Oligonucleotide Synthesis

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>